Article

COVID-19: Ophthalmic ASC Reopening Checklist released

Author(s):

Guidance from the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery, and the Outpatient Ophthalmic Surgery Society for reopening ambulatory surgery centers. 

The American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery, and the Outpatient Ophthalmic Surgery Society have come together to release an Ophthalmic ASC Reopening Checklist to facilitate the safe reopening of surgical practices. 

The organizations issued the list for reopening ambulatory surgery centers.

A guidance issued in March limited practices to emergencies and emergent care.

For nearly two months, the nation has focused on social distancing and shelter-in-place rules in an effort to reduce the spread of COVID-19.

“We are flattening the curve. It is now time to consider the process of cautiously reopening ophthalmology care and serving the growing healthcare needs of patients who deferred needed care and are at increased risk of experiencing a negative clinical outcome,” the organizations said in a statement.

While the ophthalmic community closed routine practice nationally, the groups said practice will open locally.

The decision to reopen more normal practice will be based on local and regional conditions, on public health authorities interpreting local patterns of disease, on testing availability, on institutional policies and ultimately on individual ophthalmologists.

To support the safe reopening of care, the AAO, the ASCRS, and the OOSS, developed a checklist that details specifically how to approach and manage some of the key decisions in reopening more normal practice in the COVID-19 era.

According to the groups, with respect to COVID-19 testing, facilities should adhere to state and local guidance. The statement noted that for cases at low risk for aerosolizing bodily fluids and performed under monitored anesthesia/conscious sedation, such as cataract surgery, routine preoperative RT-PCR testing should not be mandatory.

However, this may be considered for patients with risk factors on an individual basis. The groups also offered thanks to the Ambulatory Surgery Center Association (ASCA) for its contribution to the development of the checklist.

“This virus is still with us,” the groups concluded in the statement. “We simply must use our accumulated experience and scientific information and adapt to it. We must be thoughtful and careful-for our patients, our staff and colleagues, and for ourselves and our families.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.